Northwestern Mutual Wealth Management’s ImmunityBio IBRX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59.5K	Sell	6,800 -100	-1%	-$757	﹤0.01%	2471
2026 Q1	$52.9K	Sell	6,900 -1,600	-19%	-$11K	﹤0.01%	2408
2025 Q4	$16.8K	Sell	8,500 -5	-0.1%	-$11	﹤0.01%	2813
2025 Q3	$20.9K	Buy	+8,505	New	+$21.9K	﹤0.01%	2651
2023 Q2	–	Sell	-1,000	Closed	-$1.82K	–	3460
2023 Q1	$1.82K	Hold	1,000	–	–	﹤0.01%	2941
2022 Q4	$5.07K	Hold	1,000	–	–	﹤0.01%	2719
2022 Q3	$5K	Sell	1,000 -60	-6%	-$273	﹤0.01%	2683
2022 Q2	$4K	Buy	1,060 +60	+6%	+$241	﹤0.01%	2774
2022 Q1	$6K	Hold	1,000	–	–	﹤0.01%	2682
2021 Q4	$6K	Sell	1,000 -1,045	-51%	-$7.85K	﹤0.01%	2733
2021 Q3	$20K	Hold	2,045	–	–	﹤0.01%	2219
2021 Q2	$29K	Buy	2,045 +1,045	+105%	+$17.3K	﹤0.01%	2044
2021 Q1	$24K	Hold	1,000	–	–	﹤0.01%	1991
2020 Q4	$13K	Hold	1,000	–	–	﹤0.01%	2110
2020 Q3	$7K	Hold	1,000	–	–	﹤0.01%	2081
2020 Q2	$12K	Hold	1,000	–	–	﹤0.01%	1857
2020 Q1	$3K	Hold	1,000	–	–	﹤0.01%	2176
2019 Q4	$4K	Hold	1,000	–	–	﹤0.01%	2116
2019 Q3	$1K	Hold	1,000	–	–	﹤0.01%	2357
2019 Q2	$1K	Buy	+1,000	New	+$1.15K	﹤0.01%	2408

Other funds holding IBRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northwestern Mutual Wealth Management's IBRX Position: Q2 2026 in Review

Northwestern Mutual Wealth Management reduced its ImmunityBio (IBRX) stake by 1.4% in Q2 2026, selling an estimated $757 and leaving 6,800 shares worth $59.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2471.

Northwestern Mutual Wealth Management first reported a position in IBRX in Q2 2019 and has held it in 20 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

Northwestern Mutual Wealth Management held 6,800 shares of ImmunityBio worth $59.5K as of Q2 2026.
Northwestern Mutual Wealth Management sold 100 ImmunityBio shares in Q2 2026, an estimated $757.
ImmunityBio made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2471 holding.
Northwestern Mutual Wealth Management first reported a position in ImmunityBio in Q2 2019 and has held it in 20 quarters since.
405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.